Exopharm Ltd
ASX:EX1
Shareholder Yield
Current shareholder yield for 
EX1 is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
EX1 Price
Exopharm Ltd
| Average Annual Return | -62.98% |
| Standard Deviation of Annual Returns | 35.26% |
| Max Drawdown | -99% |
| Market Capitalization | 1.6m AUD |
| Shares Outstanding | 70 181 818 |
| Percentage of Shares Shorted |
N/A
|
EX1 Return Decomposition
Main factors of price return
Stock Splits
EX1's latest stock split occurred on Apr 15, 2024
The company executed a 1-for-2 stock split, meaning that for every 2 shares held, investors received 1 new share.
Before the split, EX1 traded at 0.011 per share. Afterward, the share price was about 0.0275.
The adjusted shares began trading on Apr 15, 2024. This was EX1's 2nd stock split, following the previous one in Mar 27, 2023.
